Oncopeptides operates in a highly regulated space, where environmental impacts are tightly controlled. However, we continue to improve our understanding of our environmental footprint and thereby reduce it further. In 2020, we took steps towards establishing key performance indicators and making the reduction of environmental impacts an integral component of our decision-making processes.
We continually strive to minimize the environmental impact of our own operations and those of our suppliers. Our Environmental Policy, adopted in 2017 and which all employees are expected to follow, states that environmental impact should be part of the company’s decision-making processes and that our products should not consume more natural resources than necessary. We strive to prevent pollution, reduce carbon emissions, and work actively to minimize waste and energy and water use.
Our state-of-the-art pharmaceutical development laboratory in Stockholm, which became fully operational in September 2020, is effectively a closed system with virtually no impact on the local environment. As with all modern-day labs in highly regulated geographies such as the EU, chemical handling and disposal and waste disposal is tightly controlled.
However, much of the company’s environmental impact is embedded in our products. Therefore, we focus on our suppliers and select Contract Manufacturing Organizations (CMOs) and other vendors based in countries where regulatory standards are similar to those in Sweden. We encourage all our suppliers to align with appropriate standards to minimize impacts.
Environmental efforts in 2020
The need for action to reverse severe damage to the climate took on renewed urgency in 2020, and we accelerated our efforts to reduce environmental impacts in response. Furthermore, environmental issues are likely to become increasingly commercially important and a potential differentiator.
Even before the travel restrictions brought due to the pandemic, we limited the use of flights where possible and this will continue. We held many virtual meetings during the year, and employees attended virtual training courses and congresses. We are likely to continue to develop greater use of digital
platforms going forward. If employees do fly for work in future, they will be encouraged to ensure that such trips have multiple purposes and are absolutely necessary. On a local level, employees are encouraged to take public transport where possible.
We conduct clinical studies at approximately 130 hospitals in 25 countries and our drugs are of course transported, which causes carbon emissions. We therefore include environmental impact in decisions related to shipping and where possible select companies that are more environmentally aware and transparent.
Due to the rapid growth in headcount in 2020, under normal circumstances we may have looked for larger offices. However, we have decided to adopt a more flexible approach to working from home to enable us to continue to use our existing office space. This also reduces emissions in terms of people travelling to and from the office.
During the year, our safety representative conducted checks at our Stockholm laboratory on a regular basis to ensure the safety of employees and that environmental standards were upheld.
In terms of our supply chain, we continued to work with CMOs on their management of environmental impacts. We currently use suppliers in Belgium, Canada, and Sweden where environmental standards are high, and we screen suppliers before working with them.
We will continue to improve the transparency of our environmental initiatives and performance. For example, we plan to formalize our work and measure impacts. Our intention is to present the first of these measurements in our 2022 annual report. We will continue to encourage our suppliers and contractors to align with our environmental standards and transparency through contractual obligations and supplier agreements. Lastly, at a company level and on an individual level, we will continue to make decisions that minimize our environmental impact.
Goal 13: Climate Action
Take urgent action to combat climate change and its impacts.